Publication date: Sep 19, 2025
The S2 subunit of the coronavirus Spike protein undergoes extensive conformational refolding to drive membrane fusion during viral entry. Although the HR1/HR2 six-helix bundle (6-HB) is recognized as the core mediator of fusion, the molecular driving force governing its formation remains poorly elucidated. Here, through systematic mutagenesis of the AlphaFold-predicted stem helix (SH) region in S2, followed by analysis of the resulting SC2-VLP entry phenotypes, we identified key amino acid residues within conserved helices that are present in both prefusion and postfusion Spike conformations. These elements, which we term postfusion-preserved helices (PFPHs), were found to be critical for SC2-VLP entry. Structural analysis revealed a “hydrolock” interaction between F1148 in PFPH-1 and a conserved cavity formed by 3H (I742, C749)/CH (I993, L996, I997). Deep mutational scanning demonstrated that only hydrophobic residues at F1148 were functionally viable and essential for membrane fusion, underscoring the critical role of a hydrophobic lock (“hydrolock”) interaction between F1148 and the 3H/CH cavity in membrane fusion. Furthermore, HA-replacement mutagenesis and anti-HA neutralization assays showed that significant neutralization activity was restricted to HA insertions proximal to PFPH-1, selectively inhibiting membrane fusion without affecting receptor binding. Notably, the 3H/CH cavity remains structurally stable across Spike conformations, being sequentially occupied by prefusion-L977, intermediate-F782, and postfusion-F1148. We propose a model wherein hydrolock interactions drive S2 refolding and fusion by displacing intermediate interactions. This study provides mechanistic insights into Spike dynamics and highlights hydrolock interactions as a promising target for broad-spectrum antiviral strategies.

Open Access PDF
| Concepts | Keywords |
|---|---|
| Antiviral | 3h |
| Coronavirus | Cavity |
| F1148 | Ch |
| Hydrophobic | Critical |
| Postfusion | Drive |
| Entry | |
| Fusion | |
| Hydrolock | |
| Hydrophobic | |
| Interactions | |
| Lock | |
| Membrane | |
| Postfusion | |
| Refolding | |
| Spike |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | role |
| disease | IDO | protein |
| disease | IDO | history |
| disease | IDO | process |
| disease | MESH | Infection |
| disease | MESH | middle east respiratory syndrome |
| pathway | REACTOME | Translation |
| disease | IDO | replication |
| pathway | KEGG | Virion |
| disease | MESH | sid |
| disease | IDO | host |
| pathway | REACTOME | Reproduction |
| drug | DRUGBANK | Amino acids |
| disease | IDO | infectivity |
| drug | DRUGBANK | L-Alanine |
| disease | IDO | assay |
| disease | IDO | site |
| drug | DRUGBANK | Alpha-Linolenic Acid |
| disease | IDO | cell |
| drug | DRUGBANK | Methylergometrine |
| drug | DRUGBANK | L-Cysteine |
| drug | DRUGBANK | Streptomycin |
| drug | DRUGBANK | Myricetin |
| pathway | REACTOME | Digestion |
| disease | IDO | production |
| disease | IDO | reagent |
| drug | DRUGBANK | Medical air |
| drug | DRUGBANK | Tromethamine |
| drug | DRUGBANK | Sodium lauryl sulfate |
| drug | DRUGBANK | Glycerin |
| drug | DRUGBANK | Trypsin |
| drug | DRUGBANK | Aspartame |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Proline |